MSD
Quotient Bioresearch offers biomarker multiplexing for pre-clinical and clinical studies using the latest electrochemiluminescence detection technology.
MSD™ can detect biomarkers in single and multiplex formats. Off the shelf disease-focussed assays or custom assays offer convenience and flexibility and rapid analysis. The technique also offers ultra-sensitivity, using award-winning plate reading technology coupled with Quotient Bioresearch’s experience and expertise in immunoassay.
Benefits of MSD™
- Multiplexing gives maximum data from low sample volumes
- High sensitivity compared to other immunoassay formats
- Wide dynamic analytical range
- Off-the-shelf MULTI-ARRAY™ arrays for cytonkines, chemokines, cardiac, obesity, fertility, metabolic and cell signaling pathways
- Custom methods can also be produced - ideal for pharmacokinetic studies, biotherapeutics and immunogenicity studies.
Contact us for more information and to discuss your specific needs.
Further reading
The following downloads are available as .pdf files, or get in touch for a hard copy.
- MSD™ (Meso scale discovery): MULTI-ARRAY™ technology enables the detection of biomarkers in single and multiplex formats - further information on the MSD™ technology.